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Abstract
Survival times for prostate cancer have increased substantially, meaning more survivors will be 
discharged to General Practitioners’ (GP) services. The detection of recurrence and monitoring 
of symptoms and long-term side-effects in prostate cancer survivors requires the active 
involvement of GPs in their follow-up care. In order to address this, the transition and 
discharge from hospital to primary care must be managed effectively. The objective of this 
study was to examine the preparedness, concerns and experiences of GPs in relation to their 
role in providing follow-up care to prostate cancer survivors. Purposive sampling was used to 
recruit GPs with experience in providing care to prostate cancer survivors. Twenty semi-
structured telephone interviews were conducted with GPs across England. The interviews 
were audio-recorded, transcribed verbatim and analysed using thematic analysis. Participants 
described their current role in the follow-up pathway, a number of challenges and barriers in 
assuming this role, and potential ways to resolve these and improve their involvement. They 
expressed a range of views about their preparedness and willingness to take over follow-up 
care after discharge for this group of patients. GPs had reservations about workload, lack of 
resources, expertise and deficiencies in communication with hospitals. Findings from this study 
suggest that GPs will be ready to take over the follow-up care of prostate cancer survivors if 
better information, additional training and adequate resources are provided and 
communication lines with hospital specialists are clear. Understanding the issues faced by GPs 
and overcoming identified barriers to providing follow-up care to prostate cancer survivors will 































































provide the insight necessary to make the process of transferring care from secondary to 
primary teams a more straightforward task for all stakeholders.
Keywords: patient discharge; aftercare; prostate cancer; prostate cancer survivors; cancer 
survivors; primary health care; follow-up care; General Practitioners; GP; qualitative; 
interviews
What is known about this topic? 
 NICE (2014) suggested an earlier discharge of prostate cancer patients from specialists 
to GPs for their follow-up after treatment.
 Little is known about whether GPs feel well-prepared to deal with these patients’ 
survivorship needs and that they have the appropriate services and resources to do so.
What this paper adds
 Follow-up care for prostate cancer survivors was focused mostly on the provision of 
PSA testing, overlooking the physical and psychological side-effects. 
 GPs reported that the lack of expertise, knowledge of side-effects and resources may 
prevent them from providing high-quality follow-up care to prostate cancer survivors.
 GPs suggested that timely access to secondary care through detailed treatment 
summaries along with extra training could increase their confidence.

































































The UK National Cancer Survivorship Initiative (NCSI) (Richards, Corner, & Maher, 2011) 
heralded a significant shift towards recovery, health and well-being in people diagnosed with 
and treated for cancer. Key features include personalised care planning and clinical support for 
self-management and treatment side-effects. Ten-year survival for localised prostate cancer is 
83.8% and more than 47,000 new cases are diagnosed in the UK each year (Cancer Research 
UK, 2015). Studies show an increased number of consultations among cancer survivors 
compared with controls (Nord, Mykletun, Thorsen, Bjøro, & Fosså, 2005) so the implications of 
the NCSI for the workloads of General Practitioners (GPs) dealing with prostate cancer 
survivors are likely to be considerable. 
Cancer patients want GPs and Primary Care Physicians (PCPs) to be involved in their care 
(Anvik, Holtedahl, & Mikalsen, 2006). A recent survey found that most patients were satisfied 
with the cancer care provided by their GP (Lang et al., 2017) and research indicates improved 
physical and psychosocial wellbeing of patients (Ngune, Jiwa, McManus, & Hughes, 2015) and 
higher Quality of Life (QoL) scores (Kendall et al., 2006) when this occurs. A desire among 
cancer patients for psychosocial support from GPs and PCPs in connection with fear of 
recurrence and changes in body-image and self-identity has been noted (Anvik et al., 2006; 
Kendall et al., 2006; Sisler, Brown, & Stewart, 2004). However, Adams et al. (2011) found that 
patients did not feel that their GPs were closely involved in their cancer care and Mao et al. 
(2007) reported that breast cancer patients in the USA considered PCPs not “appropriate” for a 
cancer-specific follow-up because of the limited communication with the hospital and their 
inability to manage effects of treatments. Khan, Evans and Rose (2011) found that cancer 































































survivors viewed GPs as lacking expertise in cancer and as too busy to discuss long-term 
issues, a situation exacerbated by a lack of continuity of care.
A number of studies have reported survivor concerns regarding a lack of communication 
between specialists and GPs (Adams et al., 2011; Lewis et al., 2009; Mao et al., 2009), 
particularly  in relation to unmet needs concerning information about the disease and 
treatment consequences and coordination between primary and secondary care. Lundstrøm et 
al. (2011) carried out a study of cancer patient experiences in three counties in Denmark and 
reported that one-third of the sample of 1490 patients reported problems with respect to 
coordination of care between the hospital and GP. Sondergaard et al. (2013) found that 
discharge from hospital to GP care was associated with the highest level of unmet information 
needs and also with high levels of unmet coordination needs.
Prostate cancer survivors can experience significant and long-lasting treatment side-
effects, such as urinary, sexual and bowel dysfunction. They report challenges in talking openly 
to their GPs about these problems and describe how they and their partners deal with them in 
the absence of formal support or counselling (O'Brien et al., 2011). Fear of recurrence, 
concerns about masculinity and stigmatisation has also been acknowledged as problematic 
(Rubin, Vedsted, & Emery, 2011). Patients expressed a desire for their GPs to provide them 
with information about their treatment and its side-effects and to deliver prompt advice about 
any signs or symptoms of disease re-emergence (Adams et al., 2011).  The relationship that 
men have with GPs post-discharge needs to be understood in relation to their pre-treatment 
engagement with healthcare services. 
Men are known to use GP services less than women (Wang, Hunt, Nazareth et al., 2013) 
and this reluctance to consult GPs can be particularly marked in the case of prostate-related 
concerns.  For example, a Danish study found that the majority of men with Lower Urinary 































































Tract Symptoms (LUTS) did not report them to their GP (Solvang, Elnegaard & Jarbøl, 2018). A 
more recent Danish study found that urinary incontinence was associated with higher odds of 
feeling too embarrassed to consult with a GP (Rubach et al, 2019). Men that endorse 
traditional views of masculinity are less likely to seem medical care (Himmelstein and Sanchez, 
2016) and being ill and seeking help are often perceived as a threat to masculinity, particularly 
by older men (Tannenbaum and Frank, 2011). Furthermore, GP consultations with men may 
take on a form that constrains men's ability to express emotional responses and concerns 
(Oliffe and Thorne, 2007). 
GPs’ ability to detect early signs of recurrence and treat late side-effects is a matter of 
concern for themselves and hospital specialists, despite both groups being positive about GP 
involvement (Watson et al., 2011). N vertheless, a British randomised controlled trial found no 
significant differences in reoccurrence and death rates, QoL, psychological well-being and 
satisfaction with care between GP-led and surgeon-led follow-up for colorectal cancer 
survivors (Wattchow et al., 2006). 
For some GPs, financial issues and the lack of a recall system in primary care were 
additional sources of worry (Neal, 2008).  A study in the UK (Mitchell, Burridge, Colquist, & 
Love, 2012) noted that systemic constraints, such as access to relevant clinical information, 
and workloads can act to limit GP involvement in cancer care. Research in the USA found that 
few PCPs believed that they possessed the time or the specific knowledge of side-effects to 
care for prostate cancer survivors and consequently were reluctant to take responsibility for 
them (Del Giudice, Grunfeld, Harvey, Piliotis, & Verma, 2009; Skolarus et al., 2014). 
Survivorship and follow-up care are important stages in a patient’s cancer journey. The process 































































of discharge1 and transition from secondary care to primary care may be a stressful experience 
for prostate cancer patients and have an impact on their QoL, well-being and survivorship. 
Much of the research into the role of the GP in providing cancer care has been 
conducted outside the UK (e.g. Lundstrøm et al., 2011; Skolarus et al., 2014). The UK based 
research has focused on cancer as a whole and not on specific types of cancer (e.g. Kendall et 
al., 2006) and research, in general, has been concerned with cancer care across the disease 
trajectory from diagnosis to survivorship. Therefore, the aim of this study was to investigate 
the experiences and preparedness of GPs in the UK concerning the more precise needs of 
prostate cancer survivors and the challenges that GPs encounter or anticipate in providing 
follow-up care following discharge from secondary care. Three research questions were 
addressed: 
 What are the concerns of GPs caring for prostate cancer survivors after their discharge 
from secondary care to primary care?
 How well prepared do GPs feel to provide advice concerning, and treatment for, side-
effects?  
 What resources do GPs want in order to improve their services to prostate cancer 
survivors?
Methods
A qualitative approach employing semi-structured interviews was adopted (Sullivan et 
al., 2012). The interview topic guide was developed following a review of the literature and 
discussions with clinicians (see Table 1). Topics included current experience with prostate 
cancer survivors, preparedness and willingness to take over their follow-up care and 
1 In this paper we refer to discharge as the transition of follow-up care of cancer patients from hospital-
based specialist care to primary based care following successful treatment. 































































challenges encountered. The interview questions served as a guide and participants were free 
to refer to any experiences or issues they considered relevant. The interview schedule was 
piloted with two GPs and minor amendments subsequently made.
Ethical approval was obtained from the University of East London Research Ethics 
Committee.  
Participants and recruitment
The inclusion criteria stipulated that participants be GPs in the UK. GP surgeries were 
identified using the website www.nhs.uk and invitation emails were sent to 50 GPs at their 
surgery’s email addresses. The researchers did not receive any response via this recruitment 
strategy.  
The recruitment process was slower and more difficult than was expected due to GPs’ 
workload, so potential participants were identified by doctors, clinicians and hospital staff that 
had connections with GPs and contact details for the latter were duly provided to the 
researchers. 
An invitation email with an information sheet and consent form was then sent. All GPs 
interested in participating in the study were asked to contact the researcher to arrange an 
interview. The researcher informed participants about the purpose of the research and the 
details of the procedure by means of the consent forms, which addressed specific issues such 
as the audio-recording of the interview, verbatim transcription and dissemination of findings.
Informed consent was obtained orally or in writing at the beginning of the interview, ensuring 
anonymity and confidentiality to participants. The written signed consent forms were obtained 
via fax or via email.































































Twenty-eight GPs were invited to take part and 20 agreed to do so.  The sample comprised 10 
male and 10 female GPs, with between 4 and 40 years of experience (mean = 19.1 years) from 
surgeries across London, South East and South West England. All had experience of providing 
follow-up care to prostate cancer patients following discharge from hospital-based follow-up 
care (see Table 2). 
Data collection 
Due to time pressures on GPs, telephone interviews were offered as an alternative to 
face-to-face interviews.  Consequently, all but two interviews were conducted via telephone. 
The interviews were conducted between May and September 2015. The average length of 
interviews was 14 minutes, with a range of 8 to 23 minutes. Interviews were digitally audio-
recorded and transcribed verbatim to support the analysis process by  the first author. 
Transcripts were checked for accuracy and anonymised.
Data analysis 
The data were analysed using thematic analysis (Braun & Clarke, 2006).  The stages of 
analysis outlined by Braun and Clarke (2006) were followed, including familiarisation with the 
data by repeated reading of each transcript, the generation of initial codes and the 
combination of related codes into themes based on shared features. 
The inductive analysis began with the coding of each interview followed by the linking of 
codes across interviews to build themes. The inductive approach allows the development of 
broad themes and categories developed from the raw data, which leads to a deeper 
understanding of the content of interviews (Braun & Clarke, 2006).  Data saturation was 































































considered to have been achieved when no new codes were identified, which occurred by the 
final transcript. 
Previous evidence has shown that after twelve interviews the number of new emerging 
themes was minimal, suggesting that a sample of ten to twelve interviews may be sufficient to 
enable the development of high-level meaningful themes and useful interpretations (Guest, 
Bunce, & Johnson 2006). Software for the analysis of qualitative data (NVivo 11) was 
employed.
The first author analysed the raw data and all the authors discussed the interpretation 
and clustering of the codes and themes to develop the final thematic map. The data resulting 
from the analysis and the electronic versions of the transcripts were stored on a password-
protected computer at the University of East London.
Results 
Three main themes were identified by the analysis. These are shown in Table 3 below.
Care provision and follow-up
There was a shared view that GPs should provide holistic care and not focus solely on 
cancer history and recurrence monitoring. 
“So, we do a holistic, sort of interview with them, about what their 
concerns are, you know, physical, psychological, financial, work.” (P1)
This role encompassed being an advocate and navigator, providing support and listening 
to the patients' concerns. 































































“Some patients we have are really good and a long-standing 
relationship and a lot of trust and things within that. So, they may 
come to us and they often do come and say “I don’t understand a 
word when I was in the hospital, can you explain?” (P4)
“The GPs here are mainly patients’ advocate or navigator role rather 
than actually actively doing the investigation”. (P11)
Fear of recurrence was considered one of the main concerns of patients, making them 
particularly vigilant concerning changes in their body and its functioning.
“Any symptom that they develop almost anywhere around their body, 
their first understandable worry is that could be related to their 
previous cancer. So, their expectations can be very focused on the 
possibility of reoccurrence.” (P7)
Even though most participants believed GPs should provide holistic care, many viewed 
their main role as monitoring PSA levels. 
“We just do the PSA surveillance, and then we refer back to the 
hospital when the PSA has reached a certain level.” (P19)
Some believed that because patients did not see them as specialists or particularly trust 
them to provide follow-up care they had low-expectations in any case and there was a 
recognition that although issues other than PSA testing were important they were not always 
addressed. 































































“There is quite a lot of reservation about going back to the GPs and 
patients feel scared about leaving the specialist setting and they feel 
that the experts know them really well {…} some patients may think 
that we may not have a clue and we are not specialists and they do 
not bother coming.” (P2)
Preparedness for assuming responsibility
Nine participants considered themselves well-prepared for providing follow-up care. 
This was grounded in their wide experience of managing different cancers and chronic 
conditions other than cancer.
“Yes, I think the general practices have a place for it, and I think for 
most cancers there is a sort of central coordinator of all… of care. I 
think yes I am well-prepared.” (P13)
“We are looking after diabetics, COPD, asthma, arthritis, every kind of 
patients are being monitored in primary care so stable prostate 
cancer, there is no reason why we cannot monitor them in primary 
care.” (P19)
This confidence was, to a degree, dependent on the accessibility of referral back to 
specialist care if necessary.
“As long as there is an easy pathway back into urology, I would 
imagine that patients may well be happy because they have 































































completed their treatment. So, for them, to go back to the hospital, 
you know, every six months or once a year, just to get the PSA done, I 
can see that this is not necessary” (P17)
However, this, in turn, depended on the hospital discharging the prostate cancer 
survivors in a stable condition and with a treatment plan. This was considered crucial in 
enabling GPs to successfully carry out their duties. 
“Stable prostate cancer patients can easily be managed in the 
community with the appropriate clinical protocols. If they are stable 
and controlled and have a treatment plan, I don’t have a problem 
with it.” (P12)
 Participants expressed their concerns involving follow-up and recall and test 
interpretation. They worried about the possibility of “losing” some patients between their 
follow-up appointments as they would not be able to provide them with reminders. In 
addition, they felt that their limited knowledge concerning the interpretation of PSA results 
could have a negative impact on the patients. 
“I would be worried about the monitoring; the responsibility of the 
monitoring being done totally in primary care. I think of the risk 
people getting lost to follow up, because people, you know people 
move around, they could get lost. My other reservation would be that 
GPs don’t know how to interpret the test results.” (P9)































































“We don’t have a recall system for PSA. You know, we have a recall 
system for the Smear. A recall system works really well if we have 
someone with hypertension, we’ve got a recall system to make sure 
we will see him as a minimum once a year.” (12)
Several expressed a desire for training and updating in order to improve their and their 
nurses' skills and knowledge in providing services to prostate cancer patients. 
“All the cancer treatments are developing all of the time and so if 
patients are coming out of the hospital and had treatments that you 
never heard of, obviously, it is really difficult and so I think being kept 
up to date or keeping yourself up to date is really important.” (P1)
“Nurses within the general practice is another focus who often need 
some assistance and training because some of these problems will 
present first to nurses.” (P16)
Challenges for primary care
In spite of a general willingness to take over the routine care of prostate cancer patients, 
there were concerns about the implications for resources that were already stretched and 
about the information provided to GPs at the point of discharge from secondary follow-up 
care.  































































 “This transfer of activity has to be appropriately resourced. Without 
these resources in primary care, GPs will not do this, no matter what 
consultants are going to transfer this activity.” (P7)
There was a general view that this lack of resources and time could have a negative 
impact on the patient experience. 
“One of the major problems in primary care is to get an 
appointment.” (P20)
Managing communication and information exchange with the hospital was also 
discussed, with some participants reporting a broadly positive experience. 
“So usually, usually the case is the patient's coming from (hospital), 
and letters are comprehensive and more informative.” (P5)
However, a majority expressed concerns regarding communication and collaboration 
with hospitals with respect to three issues: difficulties in communicating, concerns about lack 
of information in the discharge letter and lack of information about a follow-up plan and 
guidelines. 
“One particular problem that both sides of the system have now is the 
delay in receiving information.” (P15)































































“We don’t get that information, maybe a few weeks later, sometimes 
you see the patient before the letter. This makes it a little bit sort of 
awkward when we see them!” (P6)
The discharge letter was identified as a particular issue, in relation to information 
provision and timeliness as well as when and for what reasons they should refer patients back 
to the hospital. Participants considered the hospital discharge summary to be a key document 
and wanted it to be revised in order to focus on specific recommendations about PSA 
monitoring frequency and concerning PSA levels as well as providing better guidance for 
managing post-treatment side-effects.
 “The hospital’s discharge summaries are pretty inadequate cause all 
they give is the diagnosis, and then they give a recommendation 
about PSA and follow-up. They don’t give any other recommendation 
about managing other aspects of these men.” (P13)
“There is an uncertainty of where to refer people back for advice.” 
(P10)
Explicit and detailed guidelines about monitoring PSA, which was widely considered the 
most important task in primary care, were requested. 
“It needs to be tailored to the individual patient and it needs to be 
very, very clear on the information about how frequently PSA testing 































































is happening, and should the PSA rise above whatever limit has set in 
the letter, in particular for this patient.” (P1) 
Some advocated the provision of an appropriate and tailored follow-up care plan for 
each prostate cancer survivor including information such as guidelines about managing long-
term side-effects, monitoring recurrence symptoms and the frequency of PSA tests.
“More a plan so actually you’ve got a plan and you know what to do 
if the symptoms get worse or the PSA rises.” (P20)
“And maybe more about what the long-term plan is so you know 
what to look after like if there is a PSA level that they had been 
concerned about or for how long they are going to follow them up or 
for how long they are going to see them.” (P18)
Easier and more personalised contact and communication with hospital-based 
specialists were seen as potentially helpful.
“You know there is a big variation in gaining access to secondary care 
advice. You know some hospital, some specialities, who you can 
contact, you know whether you can call them or leave a message and 
they will call you back and help you.” (P1)
“I think we are very lucky to work with (hospital) who has a fantastic 
urology department, and we are very lucky that there is a very good 
nurse and can ask her if we have concerns.” (P19) 































































Access to support from a specialist cancer nurse was also suggested. 
Participants believed that a nurse who specialises in prostate cancer and has the 
knowledge about its treatments and side-effects would be an important source of 
support in primary care.
“More involvement of the clinical nurse specialist will be ideal for the 
community not just based only on secondary care.” (P8)
The importance of adequately preparing prostate cancer patients for discharge by 
informing them about what they should expect from GPs was emphasised. 
“The patients must be appropriately debriefed from the consultants, 
about why they are discharging to the community and they should 
convince the patient “Look here, we got a clinical protocol, go and see 
your GP if there is any problem.” (P19)
“So really is whether the patients have been told enough from the 
hospital, whether they are aware of what the symptoms are and how 
often they should be seeing us.” (P3)
Discussion
There was a consensus among participants that GPs should provide holistic care and 
support to prostate cancer patients, which is consistent with what these patients and their 































































carers desire (Kendall et al, 2006).  However, in spite of this commitment, in practice, the 
priorities of participants centred around PSA testing and interpretation of results. The 
concerns of secondary care clinicians in relation to GPs’ knowledge, especially in interpreting 
PSA results and detecting late side-effects of treatment, have been noted in previous studies 
and our participants shared these concerns (Anvik, Holtedahl, & Mikalsen; 2006; Greenfield et 
al., 2009; Kantsiper et al., 2009;  Watson et al., 2011).
There were mixed views about preparedness and willingness to be involved in the detail 
of follow-up care. Some, but not all, participants felt confident in their ability and skills and 
well-prepared for assuming this role. The concerns expressed by those lacking confidence were 
influenced by their evaluation of their skills and training, their ability to cope with the extra 
workload, their previous experience of providing care to these men and their collaboration 
with secondary care. Some felt confident about managing side-effects of treatments, though 
many did not see this as part of their role, which stands in contrast to a broad commitment to 
providing holistic care. Lack of confidence and knowledge among GPs in relation to following-
up patients with other types of cancer (i.e. breast cancer, colorectal cancer and lymphoma) has 
previously been reported (Del Giudice et al., 2009). Indeed, it has been argued that cancer 
patient needs are unlikely to be generic and instead depend on a complex mix of factors, 
including gender, type of cancer and demographic factors (Wessels et al., 2010). Watson et al. 
(2011) found that GPs described different degrees of involvement in managing erectile and 
urinary dysfunction, which is consistent with our findings. Detection of recurrence has been 
identified as the most important reason for follow-ups and fear of recurrence has been 
reported as the main reason for anxiety and need for reassurance and support in cancer 
patients (Lewis et al., 2009; Mao et al., 2009). In our study, participants stated that patients 
may not feel safe when being followed-up by them instead of hospital doctors, and studies of 
breast cancer patients have identified concerns about GPs’ ability to address cancer-specific 































































issues and to provide cancer-specific surveillance (Earle, Burstein, Winer, & Weeks, 2003; Earle 
& Neville, 2004). However, a British RCT found no significant differences in reoccurrence and 
death rates, QoL, psychological well-being and satisfaction with care between GP-led and 
surgeon-led follow-up for colorectal cancer survivors (Papagrigoriadis & Koreli, 2001).
Studies have found that lack of time and resources in primary care in the UK was of 
concern to GPs and nurses (Mitchell et al., 2012; Watson et al., 2011) and participants in our 
study expressed similar concerns, particularly in connection with funding. Participants also 
reported being unable to schedule appointments that were  long enough to address patient 
worries and were concerned about additional increases to an already heavy workload, echoing 
issues identified in studies focusing on general and colorectal cancer care (Papagrigoriadis & 
Koreli, 2001; Roorda, Berendsen, Hav rkamp, van der Meer, & de Bock, 2013).
The majority of our participants described problems and difficulties in communication 
with secondary care, commenting on the inadequacy of discharge letters and lack of clear 
information. This finding echoes the concerns of GPs in a UK study (Mitchell et al., 2012) who 
wanted improvements in written communication, and GPs in a Danish study who complained 
that discharge letters tended to focus solely on technical aspects of treatment and not on the 
more holistic issues that concerned them and their patients (Guassora, Jarbaek, & Thorson, 
2015). Our participants suggested a range of approaches to overcome the difficulties they 
experienced, including improvements to guidelines provided by hospitals, better and quicker 
access to specialists and extra training.  There was also a view that hospitals should prepare 
patients for discharge from their follow-up care, which would make GPs’ work easier and more 
successful. The issue of communication between primary and secondary care has been raised 
by a number of studies, with delays and lack of clarity frequently noted (Kripalani et al., 2007).































































Implications for practice and research
The findings of this research highlight the urgent need for preparation for discharge 
from secondary care, which should include information about the next steps in the follow-up 
care, such as management of side-effects, as well as clear instructions and guidelines relating 
to the role and responsibilities of GPs. This should include specification of the content of the 
information provided to the GPs and the provision of guidance concerning how this can be 
achieved in a timely fashion and delivered in a supportive manner. In particular, there should 
be clear and detailed guidelines for GPs about their role following discharge to avoid potential 
confusion about the respective roles and functions of GPs and hospital specialists, which can 
result in patient distress and dissatisfaction.  
The process of discharge and the appropriate steps and conditions required for its 
successful implementation need to be clearly specified and the discharge process should be 
formalised within the care pathway.
Improving communication between GPs and specialists is likely to improve patient care 
after treatment. A shared care model and survivorship care plans would enable all members of 
the cancer care team to coordinate and deliver the best care and address the lack of clear 
guidelines about the role of GPs (Earle, 2006; Grunfeld & Earle, 2010; Nissen et al., 2007; 
Skolarus et al., 2013). 
Additional funding to provide infrastructure support, such as an IT recall system, could 
help GPs to manage the extra workload. In addition, primary care could modify established GP 
practice approaches and recall systems that have been successfully used for other diseases 
and follow-ups such as smear tests.
Late-occurring and long-term physical and psychosocial side-effects require on-going 
management and GPs may require support for updating knowledge and skills in order to 































































deliver appropriate care in this regard. Future guidelines should focus not only on the 
provision of PSA tests by GPs but also on the provision of follow-up care relating to side-
effects. GPs should be aware of and prepared to provide support and advice concerning the 
management of side-effects and their impact.  Given the evidence from previous research 
concerning the challenges that men experience when raising concerns and expressing 
emotions with GPs it would useful to provide guidance and information to GPs concerning 
gender, masculinity and communication management.  This would support GPs in delivering 
the holistic care endorsed by our participants.
Future studies should recruit GPs practising in areas with large African-Caribbean and 
Africa communities. Men of these ethnic backgrounds are at a higher risk of developing 
prostate cancer and do so at a young r age, so they are likely to have particular needs. For 
example, a recent study (Margariti et al, 2019) found African Caribbean prostate cancer 
survivors believed that lack of knowledge among GPs about aspects of PCa that were of 
particular relevance to them was problematic.  While our study did not seek to address the 
issue, it is known that gay men with PCa report low satisfaction with PCa health care (NHS, 
2014), and studies have reported that particular sources of dissatisfaction include assumptions 
of heterosexuality, lack of interest and lack of appropriate knowledge among healthcare 
professionals (e.g. Rose, Ussher & Perez, 2018).  Future studies should explore this further in 
the context of UK GP-based care.
 Research should also address the views of nurses in primary care given their important 
role in providing follow-up care
London Cancer is an integrated cancer system serving North East and Central London 
and West Essex aiming to deliver comprehensive and seamless cancer care to all patients from 
diagnosis, through treatment, to living with and beyond cancer. They have recently published 































































guidelines for stratified follow-up care of prostate cancer including discharge guidance so it 
would be useful to repeat this study in the relatively near future to determine whether these 
have impacted on the GP experience (UCLH Cancer Collaborative Annual Review, 2018)
While the importance of providing psychosocial support to cancer patients throughout 
their follow-up has repeatedly been emphasised (Rubin et al., 2015), few participants in this 
study were involved in providing such support.
Strengths and limitations 
A particular strength of this study is that all participants were working in the UK. Most 
previous studies were conducted in countries whose health care systems differed from the UK 
making any generalization from these to the UK system problematic. 
Given the recent guidelines and recommendations from UCLH Cancer Collaborative, the 
concern of the NHS, cancer communities and charities is about addressing the needs of cancer 
survivors and growing the involvement of primary provision in their follow-up care. This study 
addresses an important contemporary issue and its findings could be useful and contribute to 
the examination of this phenomenon in the UK and the development of policies. 
The data were self-reported with no objective confirmation of an alternative perspective 
on issues.  The sampling method may have been biased towards GPs who had a particular 
interest in prostate cancer and the views expressed by participants may not represent the 
national population of GPs In addition the research was limited to urban geographical areas 
and the findings may differ in regional, rural and remote areas.
































































Findings from this study support previous research that GPs expressed a lack of 
confidence and knowledge in relation to following-up cancer survivors and their 
miscommunication with secondary care. The novel finding is that this study identifies a 
preliminary effective systematic approach to provide the GPs what they require in order to be 
prepared in managing prostate cancer survivors. In addition, GPs shared the need for oncology 
specialists to provide a disease-specific recommendation on cancer recurrence symptom 
monitoring as well as post-treatment survivorship issues. The findings from this study 
strengthen the call for better communication pathways to be developed for GPs and oncology 
specialists to improve the follow-up care they provide to prostate cancer survivors. 

































































Adams, E., Boulton, M., Rose, P., Lund, S., Richardson, A., Wilson, S., & Watson, E. (2011). 
Views of cancer care reviews in primary care: a qualitative study. British Journal of General 
Practice, 61(585), 173-182.
Anvik, T., Holtedahl, K. A., & Mikalsen, H. (2006). " When patients have cancer, they stop seeing 
me"–the role of the general practitioner in early follow-up of patients with cancer–a 
qualitative study. BMC Family Practice, 7(1), 19.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in 
Psychology, 3(2), 77-101.
Cancer Research UK, (2016). Prostate Cancer. Retrieved from https://www.cancerresearchuk.org/
Chapple, A., & Ziebland, S. (2002). Prostate cancer: embodied experience and 
perceptions of masculinity. Sociology of Health & Illness, 24(6), 820-841.
Choy, L. T. (2014). The strengths and weaknesses of research methodology: Comparison and 
complimentary between qualitative and quantitative approaches. IOSR Journal of 
Humanities and Social Science, 19(4), 99-104. 
Del Giudice, M. E., Grunfeld, E., Harvey, B. J., Piliotis, E., & Verma, S. (2009). Primary care 
physicians' views of routine follow-up care of cancer survivors. Journal of Clinical 
Oncology, 27(20), 3338-3345.
Earle, C. C. (2006). Failing to plan is planning to fail: improving the quality of care with 
survivorship care plans. Journal of Clinical Oncology, 24(32), 5112-5116.
Earle, C. C., Burstein, H. J., Winer, E. P., & Weeks, J. C. (2003). Quality of non–breast cancer 
health maintenance among elderly breast cancer survivors. Journal of Clinical 
Oncology, 21(8), 1447-1451. 
Earle, C. C., & Neville, B. A. (2004). Under use of necessary care among cancer survivors. 
Cancer, 101(8), 1712-1719. 































































Greenfield, D. M., Absolom, K., Eiser, C., Walters, S. J., Michel, G., Hancock, B. W., ... & 
Coleman, R. E. (2009). Follow-up care for cancer survivors: the views of clinicians. British 
Journal of Cancer, 101(4), 568.
Grunfeld, E., & Earle, C. C. (2010). The interface between primary and oncology specialty care: 
treatment through survivorship. Journal of the National Cancer Institute 
Monographs, 2010(40), 25-30.
Guassora, A. D., Jarlbaek, L., & Thorsen, T. (2015). Preparing general practitioners to receive 
cancer patients following treatment in secondary care: a qualitative study. BMC Health 
Services Research, 15(1), 202.
Guest G.,  Bunce A., & Johnson, L. (2006). How many interviews are enough? An experiment with 
data saturation and variability. Field methods, 18(1), 59-82.
Hale, S., Grogan, S., & Willott, S. (2010). Male GPs' views on men seeking medical help: a 
qualitative study. British Journal of Health Psychology, 15(4), 697-713.
Hale, S., Grogan, S., & Willott, S. (2007). Patterns of self-referral in men with  symptoms of 
prostate disease. British Journal of Health Psychology, 12(3), 403-419.
Himmelstein, M. S. & Sanchez, D.T. (2016). Masculinity impediments: Internalized masculinity 
contributes to healthcare avoidance in men and women. Journal of Health Psychology, 
21(7):1283-92.
Kantsiper, M., McDonald, E. L., Geller, G., Shockney, L., Snyder, C., & Wolff, A. C. (2009). 
Transitioning to Breast Cancer Survivorship: Perspectives of Patients, Cancer Specialists, 
and Primary Care Providers. Journal of General Internal Medicine, 24(Suppl 2), 459-466. 
doi:10.1007/s11606-009-1000-2 
Kendall, M., Boyd, K., Campbell, C., Cormie, P., Fife, S., Thomas, K., ... & Murray, S. A. (2006). 
How do people with cancer wish to be cared for in primary care? Serial discussion groups of 
patients and carers. Family Practice, 23(6), 644-650. 
Khan, N. F., Evans, J., & Rose, P. W. (2011). A qualitative study of unmet needs and interactions 
with primary care among cancer survivors. British Journal of Cancer, 105(S1), S46. 
Kripalani, S., LeFevre, F., Phillips, C. O., Williams, M. V., Basaviah, P., & Baker, D. W. (2007). 
Deficits in communication and information transfer between hospital-based and primary 































































care physicians: implications for patient safety and continuity of care. Jama, 297(8), 831-
841.
Lang, V., Walter, S., Fessler, J., Koester, M. J., Ruetters, D., & Huebner, J. (2017). The role of the 
general practitioner in cancer care: a survey of the patients’ perspective. Journal of Cancer 
Research and Clinical Oncology, 143(5), 895-904. 
Lewis, R. A., Neal, R. D., Hendry, M., France, B., Williams, N. H., Russell, D., ... & Wilkinson, C. 
(2009). Patients' and healthcare professionals' views of cancer follow-up: systematic 
review. British Journal of General Practice, 59(564), e248-e259.
Lundstrøm, L. H., Johnsen, A. T., Ross, L., Petersen, M. A., & Groenvold, M. (2011). Cross-
sectorial cooperation and supportive care in general practice: cancer patients’ 
experiences. Family Practice, 28(5), 532-540.
Mao, J. J., Bowman, M. A., Stricker, C. T., DeMichele, A., Jacobs, L., Chan, D., & Armstrong, K. 
(2009). Delivery of survivorship care by primary care physicians: the perspective of breast 
cancer patients. Journal of Clinical Oncology, 27(6), 933-938.
C. Margariti, C., Gannon, K., Thompson, R., Walsh, J., & Green, J. (2019). Experiences of UK 
African-Caribbean prostate cancer survivors of discharge to primary care. Ethnicity & 
Health,16, 1-15.
Mitchell, G. K., Burridge, L. H., Colquist, S. P., & Love, A. (2012). General practitioners’ 
perceptions of their role in cancer care and factors which influence this role. Health & Social 
Care in the Community, 20(6), 607-616.
Neal, R.D. (2008). The role of the GP in prostate cancer care. Trends in Urology & Men's Health, 
13(5), 27-30.




































































Ngune, I., Jiwa, M., McManus, A., & Hughes, J. (2015). Do patients with long-term side effects of 
cancer treatment benefit from general practitioner support? A literature review. International 
Journal of Integrated Care, 15(2).
National Institute for Health and Care Excellence (2014).Prostate cancer: diagnosis and 
treatment.Update of clinical guideline 58. (Clinical guideline 175.) www.nice.org.uk/CG175.
Nissen, M. J., Beran, M. S., Lee, M. W., Mehta, S. R., Pine, D. A., & Swenson, K. K. (2007). Views 
of primary care providers on follow-up care of cancer patients. Family Medicine, 39(7), 477.
Nord, C., Mykletun, A., Thorsen, L., Bjøro, T., & Fosså, S. D. (2005). Self‐reported health and use 
of health care services in long‐term cancer survivors. International Journal of 
Cancer, 114(2), 307-316.
O’Brien, R., Rose, P., Campbell, C., Weller, D., Neal, R. D., Wilkinson, C., ... & Watson, E. (2011). 
“I wish I’d told them”: a qualitative study examining the unmet psychosexual needs of 
prostate cancer patients during follow-up after treatment. Patient education and 
Counseling, 84(2), 200-207.
Oliffe, J., & Thorne, S. (2007). Men, masculinities, and prostate cancer: Australian and Canadian 
patient perspectives of communication with male physicians. Qualitative Health Research, 
17(2), 149-161.
Papagrigoriadis, S., & Koreli, A. (2001). The needs of general practitioners in the follow-up of 
patients with colorectal cancer. European Journal of Surgical Oncology, 27(6), 541-544. 
doi:http://dx.doi.org/10.1053/ejso.2001.1106 
Richards, M., Corner, J., & Maher, J. (2001.) The National Cancer Survivorship Initiative: new and 
emerging evidence on the ongoing needs of cancer survivors. British Journal of Cancer, 
105, S1-S4.
Roorda, C., Berendsen, A. J., Haverkamp, M., van der Meer, K., & de Bock, G. H. (2013). 
Discharge of breast cancer patients to primary care at the end of hospital follow-up: a cross-
sectional survey. European Journal of Cancer, 49(8), 1836-1844.
Rose, D., Ussher, J.M. and Perez, J. (2018). Lack of Information and Unmet Needs: Gay and 
Bisexual Men's Sexual Communication with Healthcare Professionals about Sex after 































































Prostate Cancer. In: J.M. Ussher, J. Perez and B.R.S Rosser (Eds) Gay and Bisexual Men 
Living with Prostate Cancer, (pp.132-149). New York, N.Y: Harrington Park Press.
Rubach, A., Balasubramaniam, K., Elnegaard, S., Larsen, S.E. & Jarbøl, D.E. (2019). Barriers to 
health care seeking with bothersome lower urinary tract symptoms among men—a 
nationwide study. Family Practice, 36 (6), 743–750.
Rubin, G., Berendsen, A., Crawford, S. M., Dommett, R., Earle, C., Emery, J., ... & Hamilton, W. 
(2015). The expanding role of primary care in cancer control. The Lancet Oncology, 16(12), 
1231-1272.
Rubin, G., Vedsted, P., & Emery, J. (2011). Improving cancer outcomes: better access to 
diagnostics in primary care could be critical. British Journal of General Practice, 61(586), 
317-318. 
Sisler, J. J., Brown, J. B., & Stewart, M. (2004). Family physicians' roles in cancer care. Survey of 
patients on a provincial cancer registry. Canadian Family Physician, 50(6), 889-896.
Skolarus, T. A., Holmes-Rovner, M., Northouse, L. L., Fagerlin, A., Garlinghouse, C., Demers, R. 
Y., ... & Wei, J. T. (2013). Primary care perspectives on prostate cancer survivorship: 
implications for improving quality of care. Urologic Oncology: Seminars and Original 
Investigations, 31(6), 727-732.
Skolarus, T. A., Wolf, A. M., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood III, W., ... & 
Wittmann, D. A. (2014). American Cancer Society prostate cancer survivorship care 
guidelines. CA: a Cancer Journal for Clinicians, 64(4), 225-249.
Solvang, M., Elnegaard, S., Jarbøl, D.E. (2018). Urological symptoms among 23,240 men in the 
general Danish population - concerns about symptoms, their persistence and influence on 
primary care contacts. Scandinavian Journal of Primary Health Care, 36, 227-236.
Søndergaard, E. G., Grøne, B. H., Wulff, C. N., Larsen, P. V., & Søndergaard, J. (2013). A survey 
of cancer patients’ unmet information and coordination needs in handovers–a cross-
sectional study. BMC Research Notes, 6(1), 378.
Sullivan, C., Gibson, S., & Riley, S. C. (Eds.). (2012). Doing your qualitative psychology project. 
Sage.































































Tannenbaum, C. & Frank, B . (2011).  Masculinity and Health in Late Life Men. American Journal 
of Men’s Health 5(3), 243–254
Tracy, S. J. (2010). Qualitative quality: Eight “big-tent” criteria for excellent qualitative  
Wang, Y., Hunt, K., Nazareth, I., et al. (2013).Do men consult less than women? An analysis of 
routinely collected UK general practice data. BMJ Open, 3(8)
Wattchow, D. A., Weller, D. P., Esterman, A., Pilotto, L. S., McGorm, K., Hammett, Z., ... & Silagy, 
C. (2006). General practice vs surgical-based follow-up for patients with colon cancer: 
randomised controlled trial. British Journal of Cancer, 94(8), 1116.
Wessels, H., de Graeff, A., Wynia, K., de Heus, M., Kruitwagen, C. L., Woltjer, G. T., ... & Voest, 
E. E. (2010). Gender-related needs and preferences in cancer care indicate the need for an 
individualized approach to cancer patients. The Oncologist, 15(6), 648-655.































































Table 1. Interview topic guide
 Could you tell me your opinion about the transfer of prostate 
cancer survivors from hospital-based care back to the primary 
care setting?
 What experience have you had of providing care to survivors of 
prostate cancer?
 Do you think that you receive adequate information from the 
hospital about these patients? 
 What information would you like to receive from the hospital 
concerning these patients? 
 Could you tell me how well-prepared you feel is the main 
healthcare provider for a prostate cancer patient after his 
discharge?
 Can you tell me if you have any concerns or reservations about 
having this role?
 What do you anticipate will be the demands and the 
expectations of prostate cancer patients from you following their 
discharge?
 Do you feel that you require any kind of additional 
support/training or information in order to assist you in providing 
effective care to these men? If so, what would be the best way 
of providing this?












































































































































Table 3. Themes developed through analysis of the data
Theme Description Representative quotes
1. Care provision and 
follow-up
This theme presents 
participants’ current 
involvement and role in 
prostate cancer patients’ 
follow-up care after their 
discharge from hospital 
care. Participants shared 
their opinion and 
experience in providing 
follow-up care to these 
men and what they 
consider as follow-up care.
“We just do the PSA 
surveillance, and then we 
refer back to the hospital 
when the PSA has reached 
a certain level.”
2. Preparedness for 
assuming responsibility.
This theme presents the 
professional beliefs and 
views that participants 
expressed about their 
preparedness for assuming 
the role of the main 
healthcare provider in 
prostate cancer patients 
after their discharge from 
secondary care. 
Participants described 
whether they felt well-
prepared and confident or 
not.
“I would be worried about 
the monitoring; the 
responsibility of the 
monitoring being done 
totally in primary care. I 
think of the risk people 
getting lost follow up, 
because people, you know 
people move around, they 
could get lost. My other 
reservation would be that 
GPs don’t know how to 
interpret the test results.”
3. Challenges for primary 
care
In this theme, participants 
described the challenges in 
primary care at this present 
time to assuming this role 
“The hospital’s discharge 
summaries are pretty 
inadequate cause all they 































































and taking over the 
“burden” of follow-up care. 
give is the diagnosis, and 
then they give a 
recommendation about 
PSA and follow-up, they 
don’t give any other, to my 
experience, any other 
recommendation about 
managing other aspects of 
these men.”
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